Advanced Cosmeceuticals is now proud to be the new distributor of Cocoon Medical in Australia and New Zealand. Catherine Biedermann, Managing Director of Advanced Cosmeceuticals, shares why Cocoon is the perfect addition to their best-in-class product portfolio.
Adding the Cocoon Medical range to our existing capital equipment division offers some exciting new benefits to our existing customers and to the market.
Since its launch in 2010, Cocoon Medical has demonstrated a genuine capacity to develop and manufacture innovative and reliable aesthetic devices that create demand for progressive practices. Cocoon devices, including the new Cooltech Define, offers Advanced Cosmeceuticals entry into a new aspect of the aesthetic clinical market for us: body sculpting.
The opportunity to deliver a reliable and well-priced technology to this market segment, which is in long-term rapid growth, and a range that is complementary and new to Advanced Cosmeceuticals, is exciting.
When we partnered with Lutronic in 2014, we were excited to deliver best-in-class aesthetic technology to a growing cosmetic market. In the past seven years, we have worked with new and existing customers across clinics in ANZ – from plastic surgery and dermatology to medspa and beauty – delivering technological excellence alongside our leading range of skincare brands. We have been proud to offer our customers in-demand capital technology, global education and training programs from a trusted supply partner. Adding the Cocoon Medical range to our existing capital equipment division expands on our promise to deliver efficacious, affordable and reliable devices to our customers.
About Cocoon Medical
Founded in 2010 by José Antonio Sánchez Jaime and based in Barcelona, Spain, Cocoon Medical has created an innovative portfolio of non-invasive lasers and cryoadipolysis (freeze-induced fat cell apoptosis) devices for both clinics and medspas.
All products have been developed by Cocoon’s in- house R&D team and are produced at Cocoon’s own facility in Sofia, Bulgaria. Cocoon has direct commercial operations in Europe, Latin America, Hong Kong and the US, and in addition manages a network of over 60 distributors. Cocoon’s leading cryoadipolisis and laser platform brands include Cooltech Define®, Elysion® and Primelase® platforms.
In April 2021, Sinclair Pharma, a global aesthetics company and fully-owned subsidiary of Huadong Medicine Company Limited, announced their acquisition of Cocoon Medical and expansion into energy-based devices. Sinclair Pharma is an international company operating in the fast-growth, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural- looking and minimally invasive treatments.
Chris Spooner, CEO of Sinclair, commented, ‘Non- invasive aesthetic therapy regimens frequently involve the use of both injectables and energy-based devices, and it is Sinclair’s vision to service this need by offering our customers a full range of treatment options.
Cocoon’s products combine outstanding technology, build quality and user flexibility with competitive pricing to generate an industry-leading value proposition. Moreover, our geographical reach with direct commercial affiliates in China, Korea, Russia, UAE, Europe and Latin America presents an excellent platform for our new energy-based devices operations.’
The opportunity to deliver a reliable and well-priced technology to the body contouring market segment, which is in long-term rapid growth, is exciting.
About Cooltech Define
Cooltech Define is an exclusive cryoadipolysis device that allows four applicators to be used simultaneously, offering fast treatments for impressive return on investment and high patient satisfaction.
Its unique fat freezing technology and 360° cooling plates produce superb results, so every patient will want to experience this efficient, reliable and highly cost-effective treatment.
The new Define offers four applicators working simultaneously, nine ergonomic hand pieces to choose from and capable of adapting to all areas, 360° total cooling of the treatment area and nine templates for an unbeatable patient assessment, plus a new massaging tool for use post treatment.
Cooltech Define has three different levels of suction that individually adjusts to the characteristics of the fatty tissue and the applicator being used. Each applicator also boasts a 360° cooling technology which ensures controlled and uniform cooling of the whole adipose thickness, thereby allowing a greater percentage of fat to be removed in each session.
The original and very popular Cooltech was launched in 2014. The new Define launched in 2020 with advancements that reflect Cocoon’s six years of in-clinic experience and more than one million patients across 40 countries.
Cocoon Medical is distributed in Australia and New Zealand by Advanced Cosmeceuticals
1800 242 011 | info@cocoonmedicalaustralia.com.au | cocoonmedicalaustralia.com.au
